Avian influenza virus infections in the human population are rare due to their inefficient direct human-to-human transmission. However, when humans are infected, a strong inflammatory response is usually induced, characterized by elevated levels of cytokines and chemokines in serum, believed to be important in the severe pathogenesis that develops in a high proportion of these patients. Extensive research has been performed to understand the molecular viral mechanisms involved in the H5N1 pathogenesis in humans, providing interesting insights about the virus-host interaction and the regulation of the innate immune response by these highly pathogenic viruses. In this review we summarize and discuss the most important findings in this field, focusing mainly on H5N1 virulence factors and their impact on the modulation of the innate immunity in humans.
References
[1]
Palese, P.; Shaw, M.L. Orthomyxoviridae: The viruses and their replication. In Fields virology, 5th; Howley, D.M.K.P.M., Ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2007; pp. 1647–1689.
[2]
Wise, H.M.; Foeglein, A.; Sun, J.; Dalton, R.M.; Patel, S.; Howard, W.; Anderson, E.C.; Barclay, W.S.; Digard, P. A complicated message: Identification of a novel pb1-related protein translated from influenza a virus segment 2 mrna. J. Virol. 2009, 83, 8021–8031, doi:10.1128/JVI.00826-09.
[3]
Jagger, B.W.; Wise, H.M.; Kash, J.C.; Walters, K.A.; Wills, N.M.; Xiao, Y.L.; Dunfee, R.L.; Schwartzman, L.M.; Ozinsky, A.; Bell, G.L.; et al. An overlapping protein-coding region in influenza a virus segment 3 modulates the host response. Science 2012, 337, 199–204.
[4]
Mubareka, S.; Palese, P. Influenza vaccines for the future. Rino Rappuoli, G.D.G., Ed.; 2011; pp. 3–21.
[5]
Tong, S.; Li, Y.; Rivailler, P.; Conrardy, C.; Castillo, D.A.; Chen, L.M.; Recuenco, S.; Ellison, J.A.; Davis, C.T.; York, I.A.; et al. A distinct lineage of influenza a virus from bats. Proc. Nat. Acad. Sci. USA 2012, 109, 4269–4274.
[6]
Medina, R.A.; Garcia-Sastre, A. Influenza a viruses: New research developments. Nature Rev. Microbiol. 2011, 9, 590–603, doi:10.1038/nrmicro2613.
[7]
Krauss, S.; Webster, R.G. Avian influenza virus surveillance and wild birds: Past and present. Avian. Dis. 2010, 54, 394–398, doi:10.1637/8703-031609-Review.1.
de Jong, J.C.; Claas, E.C.; Osterhaus, A.D.; Webster, R.G.; Lim, W.L. A pandemic warning? Nature 1997, 389, 554.
[10]
Claas, E.C.; de Jong, J.C.; van Beek, R.; Rimmelzwaan, G.F.; Osterhaus, A.D. Human influenza virus a/hongkong/156/97 (h5n1) infection. Vaccine 1998, 16, 977–978, doi:10.1016/S0264-410X(98)00005-X.
[11]
To, K.F.; Chan, P.K.; Chan, K.F.; Lee, W.K.; Lam, W.Y.; Wong, K.F.; Tang, N.L.; Tsang, D.N.; Sung, R.Y.; Buckley, T.A.; et al. Pathology of fatal human infection associated with avian influenza a h5n1 virus. J. Med. Virol. 2001, 63, 242–246, doi:10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N.
[12]
Liem, N.T.; Tung, C.V.; Hien, N.D.; Hien, T.T.; Chau, N.Q.; Long, H.T.; Hien, N.T.; Mai le, Q.; Taylor, W.R.; Wertheim, H.; et al. Clinical features of human influenza a (h5n1) infection in vietnam: 2004-2006. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009, 48, 1639–1646, doi:10.1086/599031.
[13]
WHO. Cumulative number of confirmed human cases of avian influenza a/(h5n1) reported to who. 2012. Available online: Http://www.Who.Int/influenza/human_animal_interface/h5n1_cumulative_table_archives/en/index.Html.
[14]
Wang, T.T.; Parides, M.K.; Palese, P. Seroevidence for h5n1 influenza infections in humans: Meta-analysis. Science 2012, 335, 1463, doi:10.1126/science.1218888.
[15]
Beare, A.S.; Webster, R.G. Replication of avian influenza viruses in humans. Arch. Virol. 1991, 119, 37–42.
[16]
Yang, Y.; Halloran, M.E.; Sugimoto, J.D.; Longini, I.M., Jr. Detecting human-to-human transmission of avian influenza a (h5n1). Emerg. Inf. Dis. 2007, 13, 1348–1353.
[17]
de Jong, M.D.; Simmons, C.P.; Thanh, T.T.; Hien, V.M.; Smith, G.J.; Chau, T.N.; Hoang, D.M.; Chau, N.V.; Khanh, T.H.; Dong, V.C.; et al. Fatal outcome of human influenza a (h5n1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12, 1203–1207, doi:10.1038/nm1477.
[18]
Thitithanyanont, A.; Engering, A.; Uiprasertkul, M.; Ekchariyawat, P.; Wiboon-Ut, S.; Kraivong, R.; Limsalakpetch, A.; Kum-Arb, U.; Yongvanitchit, K.; Sa-Ard-Iam, N.; et al. Antiviral immune responses in h5n1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein ip-10. Biochem. Biophys. Res. Commun. 2010, 398, 752–758.
[19]
Ng, W.F.; To, K.F.; Lam, W.W.; Ng, T.K.; Lee, K.C. The comparative pathology of severe acute respiratory syndrome and avian influenza a subtype h5n1--a review. Hum. Pathol. 2006, 37, 381–390, doi:10.1016/j.humpath.2006.01.015.
[20]
Yuen, K.Y.; Chan, P.K.; Peiris, M.; Tsang, D.N.; Que, T.L.; Shortridge, K.F.; Cheung, P.T.; To, W.K.; Ho, E.T.; Sung, R.; et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza a h5n1 virus. Lancet 1998, 351, 467–471.
[21]
Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nature Immun. 2010, 11, 373–384, doi:10.1038/ni.1863.
[22]
Kawai, T.; Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34, 637–650, doi:10.1016/j.immuni.2011.05.006.
[23]
Kanneganti, T.D. Central roles of nlrs and inflammasomes in viral infection. Nat. Rev. Immunol. 2010, 10, 688–698.
[24]
Kovach, M.A.; Standiford, T.J. Toll like receptors in diseases of the lung. Int. Immunopharmacol. 2011, 11, 1399–1406, doi:10.1016/j.intimp.2011.05.013.
[25]
Liu, P.; Jamaluddin, M.; Li, K.; Garofalo, R.P.; Casola, A.; Brasier, A.R. Retinoic acid-inducible gene i mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 2007, 81, 1401–1411.
[26]
Matsukura, S.; Kokubu, F.; Kurokawa, M.; Kawaguchi, M.; Ieki, K.; Kuga, H.; Odaka, M.; Suzuki, S.; Watanabe, S.; Takeuchi, H.; et al. Synthetic double-stranded rna induces multiple genes related to inflammation through toll-like receptor 3 depending on nf-kappab and/or irf-3 in airway epithelial cells. Clin. Exp. Allergy 2006, 36, 1049–1062.
[27]
Matsukura, S.; Kokubu, F.; Kurokawa, M.; Kawaguchi, M.; Ieki, K.; Kuga, H.; Odaka, M.; Suzuki, S.; Watanabe, S.; Homma, T.; et al. Role of rig-i, mda-5, and pkr on the expression of inflammatory chemokines induced by synthetic dsrna in airway epithelial cells. Int. Arch. Allergy Immunol. 2007, 143 Suppl 1, 80–83, doi:10.1159/000101411.
[28]
Le Goffic, R.; Pothlichet, J.; Vitour, D.; Fujita, T.; Meurs, E.; Chignard, M.; Si-Tahar, M. Cutting edge: Influenza a virus activates tlr3-dependent inflammatory and rig-i-dependent antiviral responses in human lung epithelial cells. J. Immun. 2007, 178, 3368–3372.
[29]
Guillot, L.; Le Goffic, R.; Bloch, S.; Escriou, N.; Akira, S.; Chignard, M.; Si-Tahar, M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded rna and influenza a virus. J. Biol. Chem. 2005, 280, 5571–5580.
[30]
Baum, A.; Sachidanandam, R.; Garcia-Sastre, A. Preference of rig-i for short viral rna molecules in infected cells revealed by next-generation sequencing. Proc. Nat. Acad. Sci. USA 2010, 107, 16303–16308.
[31]
Pulendran, B.; Palucka, K.; Banchereau, J. Sensing pathogens and tuning immune responses. Science 2001, 293, 253–256.
[32]
McGill, J.; Heusel, J.W.; Legge, K.L. Innate immune control and regulation of influenza virus infections. J. Leukoc. Biol. 2009, 86, 803–812.
[33]
Demedts, I.K.; Brusselle, G.G.; Vermaelen, K.Y.; Pauwels, R.A. Identification and characterization of human pulmonary dendritic cells. Am. J. Respir. Cell Mol. Biol. 2005, 32, 177–184, doi:10.1165/rcmb.2004-0279OC.
[34]
van Haarst, J.M.; de Wit, H.J.; Drexhage, H.A.; Hoogsteden, H.C. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung. Am. J. Respir. Cell Mol. Biol. 1994, 10, 487–492.
[35]
Sertl, K.; Takemura, T.; Tschachler, E.; Ferrans, V.J.; Kaliner, M.A.; Shevach, E.M. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 1986, 163, 436–451, doi:10.1084/jem.163.2.436.
[36]
Cochand, L.; Isler, P.; Songeon, F.; Nicod, L.P. Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am. J. Respir. Cell Mol. Biol. 1999, 21, 547–554.
[37]
Perrot, I.; Deauvieau, F.; Massacrier, C.; Hughes, N.; Garrone, P.; Durand, I.; Demaria, O.; Viaud, N.; Gauthier, L.; Blery, M.; et al. Tlr3 and rig-like receptor on myeloid dendritic cells and rig-like receptor on human nk cells are both mandatory for production of ifn-gamma in response to double-stranded rna. J. Immun. 2010, 185, 2080–2088, doi:10.4049/jimmunol.1000532.
[38]
Matsumoto, M.; Funami, K.; Tanabe, M.; Oshiumi, H.; Shingai, M.; Seto, Y.; Yamamoto, A.; Seya, T. Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immun. 2003, 171, 3154–3162.
[39]
Jarrossay, D.; Napolitani, G.; Colonna, M.; Sallusto, F.; Lanzavecchia, A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31, 3388–3393, doi:10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q.
[40]
Diebold, S.S.; Kaisho, T.; Hemmi, H.; Akira, S.; Reis e Sousa, C. Innate antiviral responses by means of tlr7-mediated recognition of single-stranded rna. Science 2004, 303, 1529–1531, doi:10.1126/science.1093616.
[41]
Lund, J.M.; Alexopoulou, L.; Sato, A.; Karow, M.; Adams, N.C.; Gale, N.W.; Iwasaki, A.; Flavell, R.A. Recognition of single-stranded rna viruses by toll-like receptor 7. Proc. Nat. Acad. Sci. USA 2004, 101, 5598–5603.
[42]
Maris, N.A.; Dessing, M.C.; de Vos, A.F.; Bresser, P.; van der Zee, J.S.; Jansen, H.M.; Spek, C.A.; van der Poll, T. Toll-like receptor mrna levels in alveolar macrophages after inhalation of endotoxin. Eur. Respir. J. 2006, 28, 622–626, doi:10.1183/09031936.06.00010806.
[43]
Striz, I.; Wang, Y.M.; Svarcova, I.; Trnka, L.; Sorg, C.; Costabel, U. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur. Respir. J. 1993, 6, 1287–1294.
[44]
Ohman, T.; Rintahaka, J.; Kalkkinen, N.; Matikainen, S.; Nyman, T.A. Actin and rig-i/mavs signaling components translocate to mitochondria upon influenza a virus infection of human primary macrophages. J. Immun. 2009, 182, 5682–5692, doi:10.4049/jimmunol.0803093.
[45]
Hsu, A.C.; Parsons, K.; Barr, I.; Lowther, S.; Middleton, D.; Hansbro, P.M.; Wark, P.A. Critical role of constitutive type i interferon response in bronchial epithelial cell to influenza infection. PLoS One 2012, 7, e32947.
[46]
Chan, M.C.; Cheung, C.Y.; Chui, W.H.; Tsao, S.W.; Nicholls, J.M.; Chan, Y.O.; Chan, R.W.; Long, H.T.; Poon, L.L.; Guan, Y.; et al. Proinflammatory cytokine responses induced by influenza a (h5n1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 2005, 6, 135.
[47]
Gray, T.E.; Guzman, K.; Davis, C.W.; Abdullah, L.H.; Nettesheim, P. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1996, 14, 104–112.
[48]
Matrosovich, M.N.; Matrosovich, T.Y.; Gray, T.; Roberts, N.A.; Klenk, H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Nat. Acad. Sci. USA 2004, 101, 4620–4624.
[49]
Chan, M.C.; Chan, R.W.; Yu, W.C.; Ho, C.C.; Chui, W.H.; Lo, C.K.; Yuen, K.M.; Guan, Y.I.; Nicholls, J.M.; Peiris, J.S. Influenza h5n1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Resp. Res. 2009, 10, 102.
[50]
Chan, R.W.; Yuen, K.M.; Yu, W.C.; Ho, C.C.; Nicholls, J.M.; Peiris, J.S.; Chan, M.C. Influenza h5n1 and h1n1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One 2010, 5, e8713.
[51]
Zeng, H.; Goldsmith, C.; Thawatsupha, P.; Chittaganpitch, M.; Waicharoen, S.; Zaki, S.; Tumpey, T.M.; Katz, J.M. Highly pathogenic avian influenza h5n1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J. Virol. 2007, 81, 12439–12449, doi:10.1128/JVI.01134-07.
[52]
Zeng, H.; Pappas, C.; Belser, J.A.; Houser, K.V.; Zhong, W.; Wadford, D.A.; Stevens, T.; Balczon, R.; Katz, J.M.; Tumpey, T.M. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human h5n1 virus infection. J. Virol. 2012, 86, 667–678.
[53]
Schmolke, M.; Viemann, D.; Roth, J.; Ludwig, S. Essential impact of nf-kappab signaling on the h5n1 influenza a virus-induced transcriptome. J. Immun. 2009, 183, 5180–5189, doi:10.4049/jimmunol.0804198.
[54]
Hui, K.P.; Lee, S.M.; Cheung, C.Y.; Ng, I.H.; Poon, L.L.; Guan, Y.; Ip, N.Y.; Lau, A.S.; Peiris, J.S. Induction of proinflammatory cytokines in primary human macrophages by influenza a virus (h5n1) is selectively regulated by ifn regulatory factor 3 and p38 mapk. J. Immun. 2009, 182, 1088–1098.
[55]
Lee, S.M.; Cheung, C.Y.; Nicholls, J.M.; Hui, K.P.; Leung, C.Y.; Uiprasertkul, M.; Tipoe, G.L.; Lau, Y.L.; Poon, L.L.; Ip, N.Y.; et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: A mechanism for the pathogenesis of avian influenza h5n1 infection. J. Infect. Dis. 2008, 198, 525–535.
[56]
Cheung, C.Y.; Poon, L.L.; Lau, A.S.; Luk, W.; Lau, Y.L.; Shortridge, K.F.; Gordon, S.; Guan, Y.; Peiris, J.S. Induction of proinflammatory cytokines in human macrophages by influenza a (h5n1) viruses: A mechanism for the unusual severity of human disease? Lancet 2002, 360, 1831–1837.
[57]
Geiler, J.; Michaelis, M.; Sithisarn, P.; Cinatl, J., Jr. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza a viruses. Med. Microbiol. Immunol. 2011, 200, 53–60, doi:10.1007/s00430-010-0173-y.
[58]
Lee, D.C.; Law, A.H.; Hui, K.; Tam, A.H.; Peiris, J.S.; Lau, A.S. Interferon dysregulation and virus-induced cell death in avian influenza h5n1 virus infections. Hong Kong Med. J. 2012, 18 Suppl 2, 12–16.
[59]
Hui, K.P.; Lee, S.M.; Cheung, C.Y.; Mao, H.; Lai, A.K.; Chan, R.W.; Chan, M.C.; Tu, W.; Guan, Y.; Lau, Y.L.; et al. H5n1 influenza virus-induced mediators upregulate rig-i in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J. Infect. Dis. 2011, 204, 1866–1878, doi:10.1093/infdis/jir665.
[60]
Thitithanyanont, A.; Engering, A.; Ekchariyawat, P.; Wiboon-ut, S.; Limsalakpetch, A.; Yongvanitchit, K.; Kum-Arb, U.; Kanchongkittiphon, W.; Utaisincharoen, P.; Sirisinha, S.; et al. High susceptibility of human dendritic cells to avian influenza h5n1 virus infection and protection by ifn-alpha and tlr ligands. J. Immun. 2007, 179, 5220–5227.
[61]
Sandbulte, M.R.; Boon, A.C.; Webby, R.J.; Riberdy, J.M. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with h5n1 or low-pathogenicity influenza viruses. Virology 2008, 381, 22–28.
[62]
Viemann, D.; Schmolke, M.; Lueken, A.; Boergeling, Y.; Friesenhagen, J.; Wittkowski, H.; Ludwig, S.; Roth, J. H5n1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J. Immun. 2011, 186, 164–173, doi:10.4049/jimmunol.0904170.
[63]
Peschke, T.; Bender, A.; Nain, M.; Gemsa, D. Role of macrophage cytokines in influenza a virus infections. Immunobiol. 1993, 189, 340–355, doi:10.1016/S0171-2985(11)80365-7.
[64]
Hofmann, P.; Sprenger, H.; Kaufmann, A.; Bender, A.; Hasse, C.; Nain, M.; Gemsa, D. Susceptibility of mononuclear phagocytes to influenza a virus infection and possible role in the antiviral response. J. Leukoc. Biol. 1997, 61, 408–414.
[65]
Lehmann, C.; Sprenger, H.; Nain, M.; Bacher, M.; Gemsa, D. Infection of macrophages by influenza a virus: Characteristics of tumour necrosis factor-alpha (tnf alpha) gene expression. Res. Virol. 1996, 147, 123–130.
[66]
Ramos, I.; Bernal-Rubio, D.; Durham, N.; Belicha-Villanueva, A.; Lowen, A.C.; Steel, J.; Fernandez-Sesma, A. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J. Virol. 2011, 85, 4421–4431, doi:10.1128/JVI.02356-10.
[67]
Wang, J.; Nikrad, M.P.; Travanty, E.A.; Zhou, B.; Phang, T.; Gao, B.; Alford, T.; Ito, Y.; Nahreini, P.; Hartshorn, K.; et al. Innate immune response of human alveolar macrophages during influenza a infection. PLoS One 2012, 7, e29879.
[68]
Sakabe, S.; Iwatsuki-Horimoto, K.; Takano, R.; Nidom, C.A.; Le, M.; Nagamura-Inoue, T.; Horimoto, T.; Yamashita, N.; Kawaoka, Y. Cytokine production by primary human macrophages infected with highly pathogenic h5n1 or pandemic h1n1 2009 influenza viruses. J. Virol. 2011, 92, 1428–1434, doi:10.1099/vir.0.030346-0.
[69]
Lee, S.M.; Gardy, J.L.; Cheung, C.Y.; Cheung, T.K.; Hui, K.P.; Ip, N.Y.; Guan, Y.; Hancock, R.E.; Peiris, J.S. Systems-level comparison of host-responses elicited by avian h5n1 and seasonal h1n1 influenza viruses in primary human macrophages. PLoS One 2009, 4, e8072.
[70]
Cheung, C.Y.; Chan, E.Y.; Krasnoselsky, A.; Purdy, D.; Navare, A.T.; Bryan, J.T.; Leung, C.K.; Hui, K.P.; Peiris, J.S.; Katze, M.G. H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocyte-derived macrophages. J. Infect. Dis. 2012, 206, 640–645.
[71]
Zhou, J.; Law, H.K.; Cheung, C.Y.; Ng, I.H.; Peiris, J.S.; Lau, Y.L. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J. Infect. Dis. 2006, 194, 61–70, doi:10.1086/504690.
[72]
Ekchariyawat, P.; Thitithanyanont, A.; Sirisinha, S.; Utaisincharoen, P. Apoptosis induced by avian h5n1 virus in human monocyte-derived macrophages involves trail-inducing caspase-10 activation. Innate Immun. 2012, 18, 390–397, doi:10.1177/1753425911410998.
[73]
Mok, C.K.; Lee, D.C.; Cheung, C.Y.; Peiris, M.; Lau, A.S. Differential onset of apoptosis in influenza a virus h5n1- and h1n1-infected human blood macrophages. J. Gen. Virol. 2007, 88, 1275–1280, doi:10.1099/vir.0.82423-0.
[74]
Haye, K.; Burmakina, S.; Moran, T.; Garcia-Sastre, A.; Fernandez-Sesma, A. The ns1 protein of a human influenza virus inhibits type i interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 2009, 83, 6849–6862.
[75]
Weinheimer, V.K.; Becher, A.; Tonnies, M.; Holland, G.; Knepper, J.; Bauer, T.T.; Schneider, P.; Neudecker, J.; Ruckert, J.C.; Szymanski, K.; et al. Influenza a viruses target type ii pneumocytes in the human lung. J. Infect. Dis. 2012, 206, 1685–1694, doi:10.1093/infdis/jis455.
[76]
Chabot, F.; Mitchell, J.A.; Gutteridge, J.M.; Evans, T.W. Reactive oxygen species in acute lung injury. Eur. Respir. J. 1998, 11, 745–757.
[77]
Imai, Y.; Kuba, K.; Neely, G.G.; Yaghubian-Malhami, R.; Perkmann, T.; van Loo, G.; Ermolaeva, M.; Veldhuizen, R.; Leung, Y.H.; Wang, H.; et al. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133, 235–249, doi:10.1016/j.cell.2008.02.043.
[78]
Smits, S.L.; van den Brand, J.M.; de Lang, A.; Leijten, L.M.; van Ijcken, W.F.; van Amerongen, G.; Osterhaus, A.D.; Andeweg, A.C.; Haagmans, B.L. Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J. Virol. 2011, 85, 4234–4245.
Weis, W.; Brown, J.H.; Cusack, S.; Paulson, J.C.; Skehel, J.J.; Wiley, D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 1988, 333, 426–431, doi:10.1038/333426a0.
[81]
Wiley, D.C.; Skehel, J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem. 1987, 56, 365–394.
[82]
Shinya, K.; Ebina, M.; Yamada, S.; Ono, M.; Kasai, N.; Kawaoka, Y. Avian flu: Influenza virus receptors in the human airway. Nature 2006, 440, 435–436.
[83]
van Riel, D.; Munster, V.J.; de Wit, E.; Rimmelzwaan, G.F.; Fouchier, R.A.; Osterhaus, A.D.; Kuiken, T. H5n1 virus attachment to lower respiratory tract. Science 2006, 312, 399, doi:10.1126/science.1125548.
[84]
Nicholls, J.M.; Chan, M.C.; Chan, W.Y.; Wong, H.K.; Cheung, C.Y.; Kwong, D.L.; Wong, M.P.; Chui, W.H.; Poon, L.L.; Tsao, S.W.; et al. Tropism of avian influenza a (h5n1) in the upper and lower respiratory tract. Nat. Med. 2007, 13, 147–149.
[85]
Rogers, G.N.; Paulson, J.C. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the h3 hemagglutinin based on species of origin. Virology 1983, 127, 361–373, doi:10.1016/0042-6822(83)90150-2.
[86]
Herfst, S.; Schrauwen, E.J.; Linster, M.; Chutinimitkul, S.; de Wit, E.; Munster, V.J.; Sorrell, E.M.; Bestebroer, T.M.; Burke, D.F.; Smith, D.J.; et al. Airborne transmission of influenza a/h5n1 virus between ferrets. Science 2012, 336, 1534–1541.
[87]
Imai, M.; Watanabe, T.; Hatta, M.; Das, S.C.; Ozawa, M.; Shinya, K.; Zhong, G.; Hanson, A.; Katsura, H.; Watanabe, S.; et al. Experimental adaptation of an influenza h5 ha confers respiratory droplet transmission to a reassortant h5 ha/h1n1 virus in ferrets. Nature 2012, 486, 420–428.
[88]
Imai, M.; Kawaoka, Y. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr. Opin. Virol. 2012, 2, 160–167.
[89]
Steel, J.; Lowen, A.C.; Mubareka, S.; Palese, P. Transmission of influenza virus in a mammalian host is increased by pb2 amino acids 627k or 627e/701n. PLoS Pathog. 2009, 5, e1000252, doi:10.1371/journal.ppat.1000252.
[90]
Van Hoeven, N.; Pappas, C.; Belser, J.A.; Maines, T.R.; Zeng, H.; Garcia-Sastre, A.; Sasisekharan, R.; Katz, J.M.; Tumpey, T.M. Human ha and polymerase subunit pb2 proteins confer transmission of an avian influenza virus through the air. Proc. Nat. Acad. Sci. USA 2009, 106, 3366–3371.
[91]
Ocana-Macchi, M.; Bel, M.; Guzylack-Piriou, L.; Ruggli, N.; Liniger, M.; McCullough, K.C.; Sakoda, Y.; Isoda, N.; Matrosovich, M.; Summerfield, A. Hemagglutinin-dependent tropism of h5n1 avian influenza virus for human endothelial cells. J. Virol. 2009, 83, 12947–12955.
[92]
Ramos, I.; Fernandez-Sesma, A. Cell receptors for influenza a viruses and the innate immune response. Front. Microbiol. 2012, 3, 117.
[93]
Xu, W.; Chen, M.; Ge, N.; Xu, J. Hemagglutinin from the h5n1 virus activates janus kinase 3 to dysregulate innate immunity. PLoS One 2012, 7, e31721.
[94]
Liu, W.C.; Lin, S.C.; Yu, Y.L.; Chu, C.L.; Wu, S.C. Dendritic cell activation by recombinant hemagglutinin proteins of h1n1 and h5n1 influenza a viruses. J. Vvirol. 2010, 84, 12011–12017, doi:10.1128/JVI.01316-10.
[95]
Eierhoff, T.; Hrincius, E.R.; Rescher, U.; Ludwig, S.; Ehrhardt, C. The epidermal growth factor receptor (egfr) promotes uptake of influenza a viruses (iav) into host cells. PLoS Pathog. 2010, 6, e1001099, doi:10.1371/journal.ppat.1001099.
[96]
Marchant, D.; Singhera, G.K.; Utokaparch, S.; Hackett, T.L.; Boyd, J.H.; Luo, Z.; Si, X.; Dorscheid, D.R.; McManus, B.M.; Hegele, R.G. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J. Virol. 2010, 84, 11359–11373.
[97]
Suguitan, A.L., Jr.; Matsuoka, Y.; Lau, Y.F.; Santos, C.P.; Vogel, L.; Cheng, L.I.; Orandle, M.; Subbarao, K. The multibasic cleavage site of the hemagglutinin of highly pathogenic a/vietnam/1203/2004 (h5n1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J. Virol. 2012, 86, 2706–2714.
[98]
Horimoto, T.; Nakayama, K.; Smeekens, S.P.; Kawaoka, Y. Proprotein-processing endoproteases pc6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 1994, 68, 6074–6078.
[99]
Horimoto, T.; Kawaoka, Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza a virus. J. Virol. 1994, 68, 3120–3128.
[100]
Stieneke-Grober, A.; Vey, M.; Angliker, H.; Shaw, E.; Thomas, G.; Roberts, C.; Klenk, H.D.; Garten, W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 1992, 11, 2407–2414.
[101]
Barbey-Morel, C.L.; Oeltmann, T.N.; Edwards, K.M.; Wright, P.F. Role of respiratory tract proteases in infectivity of influenza a virus. J. Infect. Dis. 1987, 155, 667–672.
[102]
Schrauwen, E.J.; Bestebroer, T.M.; Munster, V.J.; de Wit, E.; Herfst, S.; Rimmelzwaan, G.F.; Osterhaus, A.D.; Fouchier, R.A. Insertion of a multibasic cleavage site in the haemagglutinin of human influenza h3n2 virus does not increase pathogenicity in ferrets. J. Gen. Virol. 2011, 92, 1410–1415, doi:10.1099/vir.0.030379-0.
[103]
Schrauwen, E.J.; Herfst, S.; Leijten, L.M.; van Run, P.; Bestebroer, T.M.; Linster, M.; Bodewes, R.; Kreijtz, J.H.; Rimmelzwaan, G.F.; Osterhaus, A.D.; et al. The multibasic cleavage site in h5n1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J. Virol. 2012, 86, 3975–3984.
[104]
Brandstadter, J.D.; Yang, Y. Natural killer cell responses to viral infection. J. Innate Immun. 2011, 3, 274–279.
[105]
Arnon, T.I.; Lev, M.; Katz, G.; Chernobrov, Y.; Porgador, A.; Mandelboim, O. Recognition of viral hemagglutinins by nkp44 but not by nkp30. Eur. J. Immunol. 2001, 31, 2680–2689, doi:10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A.
[106]
Mandelboim, O.; Lieberman, N.; Lev, M.; Paul, L.; Arnon, T.I.; Bushkin, Y.; Davis, D.M.; Strominger, J.L.; Yewdell, J.W.; Porgador, A. Recognition of haemagglutinins on virus-infected cells by nkp46 activates lysis by human nk cells. Nature 2001, 409, 1055–1060.
[107]
Ho, J.W.; Hershkovitz, O.; Peiris, M.; Zilka, A.; Bar-Ilan, A.; Nal, B.; Chu, K.; Kudelko, M.; Kam, Y.W.; Achdout, H.; et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor nkp44. J. Virol. 2008, 82, 2028–2032, doi:10.1128/JVI.02065-07.
[108]
Achdout, H.; Meningher, T.; Hirsh, S.; Glasner, A.; Bar-On, Y.; Gur, C.; Porgador, A.; Mendelson, M.; Mandelboim, M.; Mandelboim, O. Killing of avian and swine influenza virus by natural killer cells. J. Virol. 2010, 84, 3993–4001.
[109]
Du, N.; Zhou, J.; Lin, X.; Zhang, Y.; Yang, X.; Wang, Y.; Shu, Y. Differential activation of nk cells by influenza a pseudotype h5n1 and 1918 and 2009 pandemic h1n1 viruses. J. Virol. 2010, 84, 7822–7831.
Stevens, J.; Blixt, O.; Tumpey, T.M.; Taubenberger, J.K.; Paulson, J.C.; Wilson, I.A. Structure and receptor specificity of the hemagglutinin from an h5n1 influenza virus. Science 2006, 312, 404–410, doi:10.1126/science.1124513.
[112]
Wang, X.; Li, M.; Zheng, H.; Muster, T.; Palese, P.; Beg, A.A.; Garcia-Sastre, A. Influenza a virus ns1 protein prevents activation of nf-kappab and induction of alpha/beta interferon. J. Virol. 2000, 74, 11566–11573.
[113]
Garcia-Sastre, A. Induction and evasion of type i interferon responses by influenza viruses. Virus Res. 2011, 162, 12–18.
[114]
Hale, B.G.; Randall, R.E.; Ortin, J.; Jackson, D. The multifunctional ns1 protein of influenza a viruses. J. Gen. Virol. 2008, 89, 2359–2376, doi:10.1099/vir.0.2008/004606-0.
[115]
Lu, Y.; Wambach, M.; Katze, M.G.; Krug, R.M. Binding of the influenza virus ns1 protein to double-stranded rna inhibits the activation of the protein kinase that phosphorylates the elf-2 translation initiation factor. Virology 1995, 214, 222–228, doi:10.1006/viro.1995.9937.
[116]
Min, J.Y.; Krug, R.M. The primary function of rna binding by the influenza a virus ns1 protein in infected cells: Inhibiting the 2'-5' oligo (a) synthetase/rnase l pathway. Proc. Nat. Acad. Sci. USA 2006, 103, 7100–7105.
[117]
Bergmann, M.; Garcia-Sastre, A.; Carnero, E.; Pehamberger, H.; Wolff, K.; Palese, P.; Muster, T. Influenza virus ns1 protein counteracts pkr-mediated inhibition of replication. J. Virol. 2000, 74, 6203–6206, doi:10.1128/JVI.74.13.6203-6206.2000.
[118]
Tan, S.L.; Katze, M.G. Biochemical and genetic evidence for complex formation between the influenza a virus ns1 protein and the interferon-induced pkr protein kinase. J. Interferon. Cytokine Res. 1998, 18, 757–766, doi:10.1089/jir.1998.18.757.
[119]
Gack, M.U.; Albrecht, R.A.; Urano, T.; Inn, K.S.; Huang, I.C.; Carnero, E.; Farzan, M.; Inoue, S.; Jung, J.U.; Garcia-Sastre, A. Influenza a virus ns1 targets the ubiquitin ligase trim25 to evade recognition by the host viral rna sensor rig-i. Cell Host Microbe 2009, 5, 439–449.
[120]
Mibayashi, M.; Martinez-Sobrido, L.; Loo, Y.M.; Cardenas, W.B.; Gale, M., Jr.; Garcia-Sastre, A. Inhibition of retinoic acid-inducible gene i-mediated induction of beta interferon by the ns1 protein of influenza a virus. J. Virol. 2007, 81, 514–524, doi:10.1128/JVI.01265-06.
[121]
Nemeroff, M.E.; Barabino, S.M.; Li, Y.; Keller, W.; Krug, R.M. Influenza virus ns1 protein interacts with the cellular 30 kda subunit of cpsf and inhibits 3'end formation of cellular pre-mrnas. Mol. Cell 1998, 1, 991–1000.
[122]
Noah, D.L.; Twu, K.Y.; Krug, R.M. Cellular antiviral responses against influenza a virus are countered at the posttranscriptional level by the viral ns1a protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mrnas. Virology 2003, 307, 386–395, doi:10.1016/S0042-6822(02)00127-7.
[123]
Chen, Z.; Li, Y.; Krug, R.M. Influenza a virus ns1 protein targets poly(a)-binding protein ii of the cellular 3'-end processing machinery. EMBO J. 1999, 18, 2273–2283.
[124]
Gao, S.; Song, L.; Li, J.; Zhang, Z.; Peng, H.; Jiang, W.; Wang, Q.; Kang, T.; Chen, S.; Huang, W. Influenza a virus-encoded ns1 virulence factor protein inhibits innate immune response by targeting ikk. Cell Microbiol. 2012, 14, 1849–1866, doi:10.1111/cmi.12005.
[125]
Burgui, I.; Aragon, T.; Ortin, J.; Nieto, A. Pabp1 and eif4gi associate with influenza virus ns1 protein in viral mrna translation initiation complexes. J. Gen. Virol. 2003, 84, 3263–3274.
[126]
Aragon, T.; de la Luna, S.; Novoa, I.; Carrasco, L.; Ortin, J.; Nieto, A. Eukaryotic translation initiation factor 4gi is a cellular target for ns1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 2000, 20, 6259–6268, doi:10.1128/MCB.20.17.6259-6268.2000.
[127]
Hale, B.G.; Jackson, D.; Chen, Y.H.; Lamb, R.A.; Randall, R.E. Influenza a virus ns1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc. Nat. Acad. Sci. USA 2006, 103, 14194–14199.
[128]
Marazzi, I.; Ho, J.S.; Kim, J.; Manicassamy, B.; Dewell, S.; Albrecht, R.A.; Seibert, C.W.; Schaefer, U.; Jeffrey, K.L.; Prinjha, R.K.; et al. Suppression of the antiviral response by an influenza histone mimic. Nature 2012, 483, 428–433, doi:10.1038/nature10892.
[129]
Kainov, D.E.; Muller, K.H.; Theisen, L.L.; Anastasina, M.; Kaloinen, M.; Muller, C.P. Differential effects of ns1 proteins of human pandemic h1n1/2009, avian highly pathogenic h5n1, and low pathogenic h5n2 influenza a viruses on cellular pre-mrna polyadenylation and mrna translation. J. Biol. Chem. 2011, 286, 7239–7247.
[130]
Kochs, G.; Garcia-Sastre, A.; Martinez-Sobrido, L. Multiple anti-interferon actions of the influenza a virus ns1 protein. J. Virol. , 2007.
[131]
Das, K.; Ma, L.C.; Xiao, R.; Radvansky, B.; Aramini, J.; Zhao, L.; Marklund, J.; Kuo, R.L.; Twu, K.Y.; Arnold, E.; et al. Structural basis for suppression of a host antiviral response by influenza a virus. Proc. Nat. Acad. Sci. USA 2008, 105, 13093–13098.
[132]
Kuo, R.L.; Krug, R.M. Influenza a virus polymerase is an integral component of the cpsf30-ns1a protein complex in infected cells. J. Virol. 2009, 83, 1611–1616, doi:10.1128/JVI.01491-08.
[133]
Twu, K.Y.; Noah, D.L.; Rao, P.; Kuo, R.L.; Krug, R.M. The cpsf30 binding site on the ns1a protein of influenza a virus is a potential antiviral target. J. Virol. 2006, 80, 3957–3965.
[134]
Spesock, A.; Malur, M.; Hossain, M.J.; Chen, L.M.; Njaa, B.L.; Davis, C.T.; Lipatov, A.S.; York, I.A.; Krug, R.M.; Donis, R.O. The virulence of 1997 h5n1 influenza viruses in the mouse model is increased by correcting a defect in their ns1 proteins. J. Virol. 2011, 85, 7048–7058.
[135]
Twu, K.Y.; Kuo, R.L.; Marklund, J.; Krug, R.M. The h5n1 influenza virus ns genes selected after 1998 enhance virus replication in mammalian cells. J. Virol. 2007, 81, 8112–8121.
Zielecki, F.; Semmler, I.; Kalthoff, D.; Voss, D.; Mauel, S.; Gruber, A.D.; Beer, M.; Wolff, T. Virulence determinants of avian h5n1 influenza a virus in mammalian and avian hosts: Role of the c-terminal esev motif in the viral ns1 protein. J. Virol. 2010, 84, 10708–10718, doi:10.1128/JVI.00610-10.
[138]
Jackson, D.; Hossain, M.J.; Hickman, D.; Perez, D.R.; Lamb, R.A. A new influenza virus virulence determinant: The ns1 protein four c-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. USA 2008, 105, 4381–4386.
[139]
Sheng, M.; Sala, C. Pdz domains and the organization of supramolecular complexes. Annu Rev Neurosci. 2001, 24, 1–29.
[140]
Zhang, H.; Li, W.; Wang, G.; Su, Y.; Zhang, C.; Chen, X.; Xu, Y.; Li, K. The distinct binding properties between avian/human influenza a virus ns1 and postsynaptic density protein-95 (psd-95), and inhibition of nitric oxide production. J. Virol. 2011, 8, 298, doi:10.1186/1743-422X-8-298.
[141]
Bavagnoli, L.; Dundon, W.G.; Garbelli, A.; Zecchin, B.; Milani, A.; Parakkal, G.; Baldanti, F.; Paolucci, S.; Volmer, R.; Tu, Y.; et al. The pdz-ligand and src-homology type 3 domains of epidemic avian influenza virus ns1 protein modulate human src kinase activity during viral infection. PLoS One 2011, 6, e27789.
[142]
Golebiewski, L.; Liu, H.; Javier, R.T.; Rice, A.P. The avian influenza virus ns1 esev pdz binding motif associates with dlg1 and scribble to disrupt cellular tight junctions. J. Virol. 2011, 85, 10639–10648.
[143]
Yu, J.; Li, X.; Wang, Y.; Li, B.; Li, H.; Li, Y.; Zhou, W.; Zhang, C.; Rao, Z.; Bartlam, M.; et al. Pdlim2 selectively interacts with the pdz binding motif of highly pathogenic avian h5n1 influenza a virus ns1. PLoS One 2011, 6, e19511.
[144]
Liu, H.; Golebiewski, L.; Dow, E.C.; Krug, R.M.; Javier, R.T.; Rice, A.P. The esev pdz-binding motif of the avian influenza a virus ns1 protein protects infected cells from apoptosis by directly targeting scribble. J. Virol. 2010, 84, 11164–11174.
[145]
Chen, W.; Calvo, P.A.; Malide, D.; Gibbs, J.; Schubert, U.; Bacik, I.; Basta, S.; O'Neill, R.; Schickli, J.; Palese, P.; et al. A novel influenza a virus mitochondrial protein that induces cell death. Nat. Med. 2001, 7, 1306–1312, doi:10.1038/nm1201-1306.
[146]
Gibbs, J.S.; Malide, D.; Hornung, F.; Bennink, J.R.; Yewdell, J.W. The influenza a virus pb1-f2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J. Virol. 2003, 77, 7214–7224, doi:10.1128/JVI.77.13.7214-7224.2003.
[147]
Zamarin, D.; Garcia-Sastre, A.; Xiao, X.; Wang, R.; Palese, P. Influenza virus pb1-f2 protein induces cell death through mitochondrial ant3 and vdac1. PLoS Pathog 2005, 1, e4.
[148]
Zamarin, D.; Ortigoza, M.B.; Palese, P. Influenza a virus pb1-f2 protein contributes to viral pathogenesis in mice. J. Virol. 2006, 80, 7976–7983, doi:10.1128/JVI.00415-06.
[149]
McAuley, J.L.; Hornung, F.; Boyd, K.L.; Smith, A.M.; McKeon, R.; Bennink, J.; Yewdell, J.W.; McCullers, J.A. Expression of the 1918 influenza a virus pb1-f2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell. Host. Microbe. 2007, 2, 240–249, doi:10.1016/j.chom.2007.09.001.
[150]
Conenello, G.M.; Zamarin, D.; Perrone, L.A.; Tumpey, T.; Palese, P. A single mutation in the pb1-f2 of h5n1 (hk/97) and 1918 influenza a viruses contributes to increased virulence. PLoS Pathog. 2007, 3, 1414–1421.
[151]
Zell, R.; Krumbholz, A.; Eitner, A.; Krieg, R.; Halbhuber, K.J.; Wutzler, P. Prevalence of pb1-f2 of influenza a viruses. J. Gen. Virol. 2007, 88, 536–546.
[152]
Hai, R.; Schmolke, M.; Varga, Z.T.; Manicassamy, B.; Wang, T.T.; Belser, J.A.; Pearce, M.B.; Garcia-Sastre, A.; Tumpey, T.M.; Palese, P. Pb1-f2 expression by the 2009 pandemic h1n1 influenza virus has minimal impact on virulence in animal models. J. Virol. 2010, 84, 4442–4450.
[153]
Bruns, K.; Studtrucker, N.; Sharma, A.; Fossen, T.; Mitzner, D.; Eissmann, A.; Tessmer, U.; Roder, R.; Henklein, P.; Wray, V.; et al. Structural characterization and oligomerization of pb1-f2, a proapoptotic influenza a virus protein. J. Biol. Chem. 2007, 282, 353–363.
[154]
Varga, Z.T.; Ramos, I.; Hai, R.; Schmolke, M.; Garcia-Sastre, A.; Fernandez-Sesma, A.; Palese, P. The influenza virus protein pb1-f2 inhibits the induction of type i interferon at the level of the mavs adaptor protein. PLoS Pathog. 2011, 7, e1002067, doi:10.1371/journal.ppat.1002067.
[155]
Varga, Z.T.; Grant, A.; Manicassamy, B.; Palese, P. Influenza virus protein pb1-f2 inhibits the induction of type i interferon by binding to mavs and decreasing mitochondrial membrane potential. J. Virol. 2012, 86, 8359–8366.
[156]
Varga, Z.T.; Palese, P. The influenza a virus protein pb1-f2: Killing two birds with one stone? Virulence 2011, 2, 542–546, doi:10.4161/viru.2.6.17812.
[157]
Hatta, M.; Gao, P.; Halfmann, P.; Kawaoka, Y. Molecular basis for high virulence of hong kong h5n1 influenza a viruses. Science 2001, 293, 1840–1842.
[158]
Mok, K.P.; Wong, C.H.; Cheung, C.Y.; Chan, M.C.; Lee, S.M.; Nicholls, J.M.; Guan, Y.; Peiris, J.S. Viral genetic determinants of h5n1 influenza viruses that contribute to cytokine dysregulation. J. Infect. Dis. 2009, 200, 1104–1112, doi:10.1086/605606.
[159]
Iwai, A.; Shiozaki, T.; Kawai, T.; Akira, S.; Kawaoka, Y.; Takada, A.; Kida, H.; Miyazaki, T. Influenza a virus polymerase inhibits type i interferon induction by binding to interferon beta promoter stimulator 1. J. Biol. Chem. 2010, 285, 32064–32074.
[160]
Graef, K.M.; Vreede, F.T.; Lau, Y.F.; McCall, A.W.; Carr, S.M.; Subbarao, K.; Fodor, E. The pb2 subunit of the influenza virus rna polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J. Virol. 2010, 84, 8433–8445, doi:10.1128/JVI.00879-10.
[161]
Vreede, F.T.; Chan, A.Y.; Sharps, J.; Fodor, E. Mechanisms and functional implications of the degradation of host rna polymerase ii in influenza virus infected cells. Virology 2010, 396, 125–134.
[162]
Vreede, F.T.; Fodor, E. The role of the influenza virus rna polymerase in host shut-off. Virulence 2010, 1, 436–439, doi:10.4161/viru.1.5.12967.
[163]
Carter, M.J. A rationale for using steroids in the treatment of severe cases of h5n1 avian influenza. J. Med. Microbiol. 2007, 56, 875–883.
[164]
Chan, P.K.; Lee, N.; Zaman, M.; Adisasmito, W.; Coker, R.; Hanshaoworakul, W.; Gasimov, V.; Oner, A.F.; Dogan, N.; Tsang, O.; et al. Determinants of antiviral effectiveness in h5n1 avian influenza. J. Iinfect. Dis. 2012, 206, 1359–1366, doi:10.1093/infdis/jis509.